EIN Presswire

FDA premarket rejections have surged since the February 2026 cybersecurity guidance.

GlobeNewswire, Inc.

First patient ever treated with Alpha DaRT for pancreatic cancer in Italy, under a clinical study conducted at the world-renowned Pancreas Institute of the University of Verona The study is the first Alpha DaRT pancreatic cancer protocol worldwide...

GlobeNewswire, Inc.

Brescia, Italy, May 07, 2026 (GLOBE NEWSWIRE) -- VCD Medical, an Italy-based startup developing a novel, minimally invasive vein closure device, has hired Denna Babul, RN, as its General Manager.

GlobeNewswire, Inc.

- Initiation of Phase 3 IMPACT DUCHENNE placebo-controlled, randomized, double-blind trial as part of Solid’s integrated, multi-trial development program designed to support registration and global regulatory authorizations for SGT-003 - - Solid...

GlobeNewswire, Inc.

The Boards of Directors of Angelini Pharma and Catalyst Pharmaceuticals have unanimously approved the acquisition of Catalyst Pharmaceuticals at 31.50 USD per share in cash, for a total consideration of approximately 4.1 billion USD, representing...

GlobeNewswire, Inc.

– Decisions on regulatory approval from EMA, UK, and Switzerland for obicetrapib and obicetrapib/ezetimibe fixed-dose combination expected in 2H26, and based on the outcomes, with potential launches by Menarini in 4Q26 in Germany and the UK – –...